A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer
BERLIN, Jordan, BENDELL, Johanna C, GRAHAM, Richard A, BRAY, Gordon L, LOW, Jennifer A, HART, Lowell L, FIRDAUS, Irfan, GORE, Ira, HERMANN, Robert C, MULCAHY, Mary F, ZALUPSKI, Mark M, MACKEY, Howard M, YAUCH, Robert L
Published in Clinical cancer research (2013)
Published in Clinical cancer research (2013)
Get full text
Journal Article
Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS-Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance
Aronchik, Ida, Dai, Yumin, Labenski, Matt, Barnes, Carmen, Jones, Terri, Qiao, Lixin, Beebe, Lisa, Malek, Mehnaz, Elis, Winfried, Shi, Tao, Mavrommatis, Konstantinos, Bray, Gordon L, Filvaroff, Ellen H
Published in Molecular cancer research (01.02.2019)
Published in Molecular cancer research (01.02.2019)
Get full text
Journal Article
Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors
Von Hoff, Daniel D, Rasco, Drew W, Heath, Elisabeth I, Munster, Pamela N, Schellens, Jan H M, Isambert, Nicolas, Le Tourneau, Christophe, O'Neil, Bert, Mathijssen, Ron H J, Lopez-Martin, Jose A, Edenfield, W Jeff, Martin, Miguel, LoRusso, Patricia M, Bray, Gordon L, DiMartino, Jorge, Nguyen, Aaron, Liu, Kejian, Laille, Eric, Bendell, Johanna C
Published in Clinical cancer research (01.09.2018)
Published in Clinical cancer research (01.09.2018)
Get full text
Journal Article
A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies
CAMIDGE, D. Ross, HERBST, Roy S, BRAY, Gordon, MENDELSON, David, GORDON, Michael S, GAIL ECKHARDT, S, KURZROCK, Razelle, DURBIN, Blythe, ING, Josephine, TOHNYA, Tanyifor M, SAGER, Jason, ASHKENAZI, Avi
Published in Clinical cancer research (15.02.2010)
Published in Clinical cancer research (15.02.2010)
Get full text
Journal Article
PB1889: KB‐LANRA 1001: A PHASE 1B/2 STUDY ON SAFETY, PK, PD, AND PRELIMINARY EFFICACY OF THE SELECTIVE SYK INHIBITOR LANRAPLENIB IN COMBINATION WITH THE FLT3 INHIBITOR GILTERITINIB, IN FLT3‐MUTATED R/R AML
Patel, Anand, Michaelis, Laura, Schiller, Gary, Swords, Ronan, Morris, Lawrence E., Carvajal, Luis A., Bray, Gordon, Olek, Elizabeth A., Cutler, Richard, Dimartino, Jorge, Stein, Eytan
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study
Cheah, Chan Yoon, Belada, David, Fanale, Michelle A, Janikova, Andrea, Czucman, Myron S, Flinn, Ian W, Kapp, Amy V, Ashkenazi, Avi, Kelley, Sean, Bray, Gordon L, Holden, Scott, Seymour, John F
Published in The Lancet. Haematology (01.04.2015)
Published in The Lancet. Haematology (01.04.2015)
Get more information
Journal Article
A Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with Hemophilia
Goedert, James J, Kessler, Craig M, Aledort, Louis M, Biggar, Robert J, Andes, W. Abe, White, Gilbert C, Drummond, James E, Vaidya, Kampala, Mann, Dean L, Eyster, M. Elaine, Ragni, Margaret V, Lederman, Michael M, Cohen, Alan R, Bray, Gordon L, Rosenberg, Philip S, Friedman, Robert M, Hilgartner, Margaret W, Blattner, William A, Kroner, Barbara, Gail, Mitchell H
Published in The New England journal of medicine (26.10.1989)
Published in The New England journal of medicine (26.10.1989)
Get full text
Journal Article
KB-Lanra 1001: A Phase 1b/2 Study of Safety, PK, PD, and Preliminary Efficacy of the Selective SYK Inhibitor Lanraplenib in Combination with the FLT3 Inhibitor Gilteritinib in FLT3-Mutated R/R AML
Arnan, Monteserrat, Patel, Anand Ashwin, Esteve, Jordi, Morris, Lawrence, Schiller, Gary J., Swords, Ronan T., Alonso-Dominguez, Juan M., Michaelis, Laura C., Daver, Naval, Carvajal, Luis A., Bray, Gordon, Olek, Elizabeth, Cutler, Richard E., DiMartino, Jorge F., Stein, Eytan M.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Erythropoietin response to critical illness
Krafte-Jacobs, B, Levetown, M L, Bray, G L, Ruttimann, U E, Pollack, M M
Published in Critical care medicine (01.05.1994)
Published in Critical care medicine (01.05.1994)
Get more information
Journal Article
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Entospletinib in Combination with Intensive Induction and Consolidation Chemotherapy in Adults with Newly Diagnosed Nucleophosmin 1-mutated Acute Myeloid Leukemia
Byrd, John C., Cortes, Jorge E., Minden, Mark D., Oellerich, Thomas, Stein, Eytan M., Elder, Jenna, Kumar, Pavan, Bray, Gordon, DiMartino, Jorge, Stock, Wendy
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Entospletinib in Combination with Intensive Induction and Consolidation Chemotherapy in Adults with Newly Diagnosed N ucleophosmin 1- mutated Acute Myeloid Leukemia
Byrd, John C., Cortes, Jorge E., Minden, Mark D., Oellerich, Thomas, Stein, Eytan M., Elder, Jenna, Kumar, Pavan, Bray, Gordon, DiMartino, Jorge, Stock, Wendy
Published in Blood (05.11.2021)
Published in Blood (05.11.2021)
Get full text
Journal Article
Measurement of active coagulation factors in Autoplex-T with colorimetric active site-specific assay technology
Lundblad, R L, Bergstrom, J, De Vreker, R, Bray, G, Gomperts, E, Baker, D, Kingdon, H S, Mann, K G, Hartshorn, J, Jenny, R J
Published in Thrombosis and haemostasis (01.11.1998)
Published in Thrombosis and haemostasis (01.11.1998)
Get more information
Journal Article
Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia
Rabkin, C S, Hilgartner, M W, Hedberg, K W, Aledort, L M, Hatzakis, A, Eichinger, S, Eyster, M E, White, 2nd, G C, Kessler, C M, Lederman, M M
Published in JAMA : the journal of the American Medical Association (26.02.1992)
Published in JAMA : the journal of the American Medical Association (26.02.1992)
Get more information
Journal Article
A phase Ia study of CC-90003, a selective extracellular signal-regulated kinase (ERK) inhibitor, in patients with relapsed or refractory BRAF or RAS-mutant tumors
Mita, Monica M., LoRusso, Patricia, McArthur, Grant A., Kim, Edward S., Bray, Gordon L., Hock, Nanette H, Laille, Eric J., Aronchik, Ida, Filvaroff, Ellen, Wu, Xiaoling, Bendell, Johanna C.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article